Skip to main content
Premium Trial:

Request an Annual Quote

Empire Genomics Lands $1M Financing

NEW YORK (GenomeWeb News) — Rand Capital and SCP Buffalo Incubator Innovate NY Fund said yesterday that they have invested $1 million in privately held molecular diagnostics firm Empire Genomics.

Based in Buffalo, NY, Empire Genomics offers testing products and services for cancer disease management that enable physicians to improve their diagnostic capabilities and tailor specific therapeutic treatments using patient DNA.

Empire Genomics was created in 2006 from research at Buffalo's Roswell Park Cancer Institute. The company has proprietary assays for prostate cancer and multiple myeloma, and its customers include hospitals, pharmaceutical clients, and academic centers.

The company said it will use the new funds to accelerate the pace of its growth by acquiring new technologies, growing staff, and increasing test offerings.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.